Answers are grounded in this paper and cite their sources.
Survey reveals mental health impacts and quality of care issues in patients with alloimmunization, suggesting improvements are needed.
Objective: The purpose of this study was to investigate mental health and impacts upon daily life in patients with a history of pregnancy alloimmunization, and secondarily to examine the relationship between disease severity and quality of care on these outcomes. Study Design: This was a survey administered between November 2022 – February 2023 to U.S. adults with a history of red cell alloimmunization in pregnancy. Mental health outcomes, quality of care, and daily life impacts were reported. Results: The survey was completed by 127 alloimmunized adults. Anxiety (90.6%), guilt (74.8%), self-doubt (68.0%), isolation (71.4%), depression (68.3%), and symptoms of post-traumatic stress disorder (PTSD) (61.3%) were frequently reported. Mental health support was offered in 24.4%. Respondents reporting a high quality of care in their alloimmunized pregnancies (rating of 8/10 or higher) were significantly less likely than those who perceived receiving lower-quality care to report feelings of guilt (p=0.0006), self-doubt (p=0.04), depression (p=0.03), and symptoms of PTSD (p=0.001). Conclusion: Despite the pervasive patient burden, mental health support was infrequently offered, and patients reported low satisfaction with continuity of care and their providers’ knowledge of alloimmunization. Clinicians interacting with alloimmunized patients must employ a comprehensive patient-centered approach to address the significant disease burden.
No takes yet. Share an insight, caveat, or question.
Sherwood et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: